CSF Conversion Assay May Identify MCI Due To Probable Lewy Body Disease, Study Indicates
July 16, 2021
Healio (7/15, Ernst) reports, “A cerebrospinal fluid alpha-synuclein real-time, quaking-induced conversion assay demonstrated efficacy as a ‘robust biomarker’ for identifying mild cognitive impairment [MCI] due to probable Lewy body disease,” investigator...